Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Tables)

9 Months Ended

Aug. 31, 2021

As of August 31, 2021, and November 30, 2020, the note payable obligation was as follows:

	August 31, 2021			November 30, 2020
Note payable	$	2,683,433		$	6,008,433
Unamortized debt issuance costs		(19,757	)		(67,219	)
Net note payable	$	2,663,676		$	5,941,214

Current portion of note payable	$	2,663,676		$	3,100,000
Long-term note payable, net of debt issuance costs		—			2,841,214
Total	$	2,663,676		$	5,941,214

Interest expense on the note payable for the three and nine months ended August 31, 2021 and August 31, 2020 was as follows:

	For the three months ended August 31, 2021		For the nine months ended August 31, 2021
Interest expense on notes payable	$	25,862	$	99,294
Debt issuance costs		12,390		47,462
Total interest expense	$	38,252	$	146,756

	For the three months ended August 31, 2020		For the nine months ended August 31, 2020
Interest expense on notes payable	$	63,560	$	254,945
Debt issuance costs		20,193		67,012
Total interest expense	$	83,753	$	321,957